Created in 2017 (France), Nephrocheck own 144 sister brands and 2617 competing brands. The Nephrocheck brand is owned by BIOMERIEUX, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0013280286. Nephrocheck belongs to the Medical Diagnostics & Research business sector.
Share price and profitability of the share BIOMERIEUX (Nephrocheck)
Buy BIOMERIEUX share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
BIOMERIEUX
(Nephrocheck)
over 5 years*
EUR 145.86
Stock market history BIOMERIEUX (Nephrocheck)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
